FACTS ABOUT HEMGENIX REVEALED

Amount of qualified clients: CDEC talked about the uncertainty in the number of clients with reasonably significant to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who are labeled as owning moderate or moderate ailment could have a critical bleeding pheno